Epidermal growth factor (EGF) and insulin induced similar effects in isolated rat adipocytes. To determine whether EGF and insulin produced similar effects through the same mechanisms, we focused on lipolysis. Insulin inhibited the lipolysis stimulated by isoproterenol, glucagon (either alone or in combination with adenosine deaminase), adenosine deaminase itself, or forskolin. In contrast, EGF did not inhibit the lipolysis stimulated by forskolin or by hormones when the cells were also incubated with adenosine deaminase. The effect of insulin, but not that of EGF, on isoproterenol-stimulated lipolysis disappeared when adipocytes were incubated with 1 P~VI wortmannin. These results indicate that EGF and insulin affected lipolysis through different mechanisms. We observed that EGF, but not insulin, increased cytosolic Ca *+ The effect of EGF, but not that of insulin, . disappeared when the cells were incubated in a Ca*+-free medium. We suggest that EGF, but not insulin, mediate its antilipolytic effect through a Ca *+-dependent mechanism which, however, do not involve Ca*+-activated protein kinase C isoforms. This is based on the following: 1) phorbol 12-myristate 13-acetate affected lipolysis in an opposite way to that of EGF; and 2) the protein kinase C inhibitor bisindolylmaleimide GF 109203X did not affect the antilipolytic action of EGF. Our results indicate that the antilipolytic effect of EGF resembles more that of vasopressin than that of insulin. (Endocrinology 137: 4181-4188, 1996) E PIDERMAL GROWTH factor (EGF), a small polypeptide with a mol wt of about 6K, has dual effects in adipose tissue. It stimulates proliferation and blocks differentiation (lipid accretion) of adipocyte precursor cells in culture (1) and in viva (2). In contrast, available data indicate that in differentiated adipocytes, EGF stimulates lipid accumulation: EGF increases acetyl-CoA carboxylase activity, stimulates lipogenesis (3), and inhibits hormone-stimulated lipolysis (4). Kurachi et al. (5) found that EGF is involved in the induction of obesity in ovariectomized mice. This dual effect of EGF (inhibition of preadipocyte differentiation but promotion of adipogenesis in differentiated adipocytes) was observed in cultured 3T3-Ll cells (6).
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of the low K, [cyclic GMP (cGMP) inhibited] phosphodiesterase (see Ref. 14 for review). This effect results in a decrease in the hormone-induced CAMP signal, in a lower activation of protein kinase A, and therefore, of the hormone-sensitive lipase, which ultimately leads to reduced lipolysis (15). In the last 2 years, several reports suggested that activation of phosphatidylinositol 3-kinase is necessary for the antilipolytic action of insulin (16, 17) .
The effects of EGF in differentiated adipocytes are therefore similar to those of insulin. EGF and insulin receptors are both ligand-activated tyrosine-kinases (7-9). The autophosphorylated EGF receptor and the phosphorylated IRS-l [the main substrate of the insulin receptor (lo)] serve as docking points to several SH-2 (for Src homology) domain-containing proteins (11). As a result, both EGF and insulin activate the Ras/Raf-1 /MAP kinase cascade and other signalling pathways in many cell types (for recent reviews see Refs. 12 and 13).
Our previous studies on the antilipolytic effect of EGF suggested that this is a consequence of an action at the level of the adenylylcyclase control by G proteins rather than an activation of some phosphodiesterase (4). However, EGF, like insulin, activates phosphatidylinositol 3-kinase in several cell systems (18). The aim of the studies presented here was to determine whether insulin and EGF induced their antilipolytic effects through the same mechanism. To do so, we first compared the effects of EGF and insulin on lipolysis stimulated by several mechanisms. Then, we studied the involvement of wortmannin-sensitive substrates and of calcium ions in their antilipolytic effects. The results suggest that the effect of EGF on lipolysis resembles more the action of vasopressin than that of insulin. (30), and also the inhibition of hormone-stimulated lipolysis (17). Therefore, to determine whether the differences in the antilipolytic action of insulin and EGF are the consequence of differences in the signaling mechanism, we incubated isolated adipocytes in the absence and in the presence of wortmannin (1 PM) (an inhibitor of phosphatidylinositol3-kinase (31)) for 30 min before the addition of hormones. The results are shown in Fig. 3 . Wortmannin completely abolished the antilipolytic effect of insulin. However, the effect of EGF was only moderately reduced (30% inhibition without wortmannin, and 25% inhibition in the presence of wortmannin). In search of differences in EGF and insulin signaling, we focused on Ca'+. First, we studied the effect of EGF on cytosolic free Ca '+ in Fura-2-loaded adipocytes.
As shown in Fig. 4 , EGF increased cytosolic Ca2+ concentration.
We performed eleven experiments like that shown in Fig. 4 . The mean basal Ca2+ concentration was 155 t 3 nM (similar basal cytosolic Ca2+ concentration was reported by others (32)) and increased to 184 + 5 nM after the addition of EGF (P < 0.001, determined by the paired Student's t test). This effect was, however, quite moderate.
As shown in the same Fig. 4 glycerol/30 min X lo5 cells: 19.5 t-0.7,11.8 2 0.9, P < 0.01, and 13.0 +-0.3, P < 0.001 in isoproterenol-, (isoproterenol+EGF)-, and (isoproterenol+vasopressin)-treated cells respectively).
However, none of these parameters were affected by EGF or vasopressin in forskolin-stimulated cells (CAMP in pmol/105 cells: 17.4 +-0.7, 18.1 2 1.7, and 16.8 + 0.6 in 5 pM forskolin-, (forskolin+EGF)-, and (forskolin+vasopressin)-treated cells respectively, nonsignificant differences; lipolysis in nmol glycerol / 30 min X lo5 cells: 57 -f 2, 56 -t 1, and 58 2 1 in forskolin-, (forskolin+EGF)-, and (forskolin+vasopressin)-treated cells, respectively, nonsignificant differences). The antilipolytic effect of EGF and vasopressin were of similar magnitude, as shown above, but the increase in cytosolic Ca*+ was much higher when the cells were stimulated with vasopressin than with EGF (see Fig. 4 ). Therefore, we studied the relationship between the increase in cytosolic Ca2+ and the antilipolytic effect of vasopressin in a doseresponse experiment.
Vasopressin increased cytosolic Cazt in a dose-dependent manner (Fig. 5, upper (100 nM) (4) and vasopressin (300 nM) (see Fig. 5 ) induced additive antilipolytic effects. In this experiment, 100 nM isoproterenol increased lipolysis from a basal 7 2 1 nmol glycerol/30 min X lo5 cells to 38 t-2 nmol glycerol/ 30 min X lo5 cells (P < 0.001). When EGF or vasopressin were added in combination with isoproterenol, lipolysis was reduced to 28 +-1 and to 28 t-2 nmol glycerol/30 min X lo5 cells, respectively (P < 0.05 7~. isoproterenol value). When both EGF and vasopressin were added simultaneously, the isoproterenol-stimulated lipolysis was not further reduced (26 -C 1 nmol glycerol/30 min X lo5 cells (differences were nonsignificant either ZJS. IS0 + EGF or IS0 + VP). Insulin requires the presence of Ca2+ ions in the incubation medium to produce maximal effects (34). Therefore, we studied the requirement of extracellular Ca2+ for the antilipolytic effect of insulin, EGF, and vasopressin.
As shown in Fig. 6 , isoproterenol-stimulated lipolysis was somewhat lower in the absence of Ca*+ ions. The antilipolytic effect of insulin was also reduced by the lack of Ca2+ (71% inhibition in the presence of Ca2+, 58% in its absence). We have reported that EGF enhances the sensitivity of the G,-mediated activation of adenylylcyclase to the inhibitory (G,-mediated) effect of adenosine (4). Therefore, we also compared the effects of EGF and PMA on the inhibition of isoproterenol-stimulated lipolysis by PIA. As shown in Fig. 8 , EGF decreased IC,, from control value of 30 t-2 nM to 11 f-1 nM (P < 0.001). EGF does not affect however the maximal inhibitory effect of PIA. PMA not only did not decrease IC,,, but actually increased this parameter to 39 2 2 nM (P < 0.01). PMA also reduced the maximal inhibitory effect of PIA. To rule out any role of some of the Ca2+-dependent protein kinase C isoforms in EGF inhibition of hormone-stimulated lipolysis,
we studied the effect of the protein kinase C-inhibitor bisindolylmaleimide GF 109203X (36). The results are shown in Table 3 . The incubation of adipocytes for 30 min with 2 PM GF 109203X completely prevented the effect of PMA on isoproterenol-stimulated lipolysis. The effect of EGF was, however, insensitive to this protein kinase C inhibitor.
Discussion
There are few studies on the effect of EGF in mature adipocytes (3) (4) (5) (6) but PMA decreases, the sensitivity of isoproterenol-stimulated lipolysis to inhibition by fl-(phenylisopropyl)adenosine. The effect of increasing concentrations of PIA on lipolysis stimulated by 100 nM isoproterenol plus 2 pg adenosine deaminase/ml was determined in the absence of further additions (control: 0) or in the presence of either 100 nM EGF (m) or 100 nM PMA (0). Results are the mean of duplicate values.
lipolysis. Therefore, both promote all the actions required for the efficient accumulation of triacylglycerols in adipocytes. Our findings on the short-term effects of EGF are in keeping with those on the long-term effect reported by Adachi et al. (6). They showed that EGF actually increased the triacylglycerol content in 3T3-Ll adipocytes, when the peptide was added for 10 days on and after the sixth day after the induction of differentiation.
Because antilipolysis is the best known effect among those of insulin in adipocytes, we centered our studies on this pathway to determine whether EGF and insulin produced a similar effect through the same or different mechanism. Insulin stimulates the phosphorylation, which results in the activation, of one of the phosphodiesterase isoforms: the low K, (cGMP inhibited) phosphodiesterase (37). Recent studies indicate that this effect is sufficient to account for the antilipolytic effect of insulin (38). Our data concerning the insulin effect (see Table 1 In search of differences in EGF and insulin signalling, we focused on Cazt because insulin does not increase intracellular Ca2+ in adipocytes (33) and, although it was mentioned that EGF had no effect on cytosolic Ca2+ in mature adipocytes (33), it is known that the EGF receptor phosphorylates the y-isoform of phosphoinositide-specific phospholipase C (40). This effect of EGF results in the increase in cytosolic free Ca2+ concentration in many cells types including NIH 3T3 cells (41). We found that EGF, but not insulin, increased this messenger in isolated adipocytes (see Fig. 4 ). Indeed, this effect was much milder than that of vasopressin.
The results obtained in a Ca2+-free medium indicate that the increase in cytosolic free Ca 2t, induced by both EGF and vasopressin, depends on extracellular Ca2' either because they stimulate Ca 2+ inflow, or because extracellular Ca2+ is required for maintenance of the internal stores. Vasopressin infusion to fasted rats has a rapid antilipolytic effect (42). These authors did not observe such an effect in isolated adipocytes (43 we observed that such a large increase in Cazt is not required to reach maximal antilipolysis (see Fig.  5 ). In fact, lipolysis was very sensitive to moderate increases in Ca2+. Therefore, we propose that both EGF and vasopressin decrease hormone-stimulated lipolysis through a similar Ca2+-dependent mechanism. Among the mediators of Ca2~+, we studied the involvement of protein kinase C in the antilipolytic effect of EGF. Protein kinase C is involved in some of the effects of EGF in several cell types, including the late phase activation of p70shk (44,45) and the stimulation of phospholipase D (46) in 3T3 cells. Other effects of EGF are, however, independent of protein kinase C (47, 48). Our results suggest that protein kinase C induces an effect on CAMP and lipolysis opposed tot that of EGF. This conclusion is based in the studies involving PMA and the bisindolylmaleimide GF 109203X. It should be noted that PMA only activate diacylglycerol-stimulated protein kinase C isoforms (49). Among them, those which are also Ca2'-dependent: cy, PI/PII, and y (50). Those isoforms are also the most sensitive to GF 109203X (51). Therefore, our results, although do not exclude the involvement of all protein kinase C isoforms (specially & which is completely insensitive to PMA (50) and rather insensitive to the GF 109203X (51)), do exclude the involvement of the classical protein kinase C isoforms which are sensitive to both PMA and GF 109203X.
The effect of protein kinase C on the CAMP generating system is complex and appears to be cell-specific (52). Naghshineh et al. (53) found that purified protein kinase C activates adenylylcyclase from adipocyte membranes. In addition to this effect, it is conceivable that protein kinase C could phosphorylate and inactivate the function of some Gi protein in adipocytes, as it was observed in intact hepatocytes (54). Our results showing that PMA decreases the sensitivity of isoproterenol-stimulated lipolysis to the inhibition by PIA (Fig. 8) , and those of Chambaut-Guerin and Thomopoulos (55) (who observed that the effect of PMA on CAMP was prevented by the pretreatment of the cells with pertussis toxin), are in keeping with this latter hypothesis.
The results reported herein (Fig. 8) indicate that EGF produces an opposite effect to that of Ca2+ -sensitive protein kinase C isoforms on the sensitivity of adenylylcyclase to Gi proteins: EGF increase the sensitivity of isoproterenol-stimulated adenylylcyclase to the inhibitory effect of PIA. In a previous report (4), we showed that the effect of EGF on PIA-inhibited lipolysis was only observed if adenylylcyclase was stimulated by G,-coupled receptors. In conclusion, we observed that EGF and insulin promote similar effects in mature adipocytes.
Although both EGF and insulin receptors share common capabilities in their respective mechanisms of action, our results demonstrate that, at least one of these effects, the antilipolysis, is mediated by different mechanisms.
In particular, the effect of EGF requires of Ca2'-, although Ca'+-activated protein kinase C isoforms are not involved.
